• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算预测突变 HIV-1 蛋白酶切割靶序列。

In silico prediction of mutant HIV-1 proteases cleaving a target sequence.

机构信息

Department of Chemistry, University of Copenhagen, Copenhagen, Denmark.

Department of Biology, University of Copenhagen, Copenhagen, Denmark.

出版信息

PLoS One. 2014 May 5;9(5):e95833. doi: 10.1371/journal.pone.0095833. eCollection 2014.

DOI:10.1371/journal.pone.0095833
PMID:24796579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4010418/
Abstract

HIV-1 protease represents an appealing system for directed enzyme re-design, since it has various different endogenous targets, a relatively simple structure and it is well studied. Recently Chaudhury and Gray (Structure (2009) 17: 1636-1648) published a computational algorithm to discern the specificity determining residues of HIV-1 protease. In this paper we present two computational tools aimed at re-designing HIV-1 protease, derived from the algorithm of Chaudhuri and Gray. First, we present an energy-only based methodology to discriminate cleavable and non cleavable peptides for HIV-1 proteases, both wild type and mutant. Secondly, we show an algorithm we developed to predict mutant HIV-1 proteases capable of cleaving a new target substrate peptide, different from the natural targets of HIV-1 protease. The obtained in silico mutant enzymes were analyzed in terms of cleavability and specificity towards the target peptide using the energy-only methodology. We found two mutant proteases as best candidates for specificity and cleavability towards the target sequence.

摘要

HIV-1 蛋白酶是定向酶重新设计的有吸引力的系统,因为它具有各种不同的内源性靶标、相对简单的结构和良好的研究基础。最近,Chaudhury 和 Gray(结构(2009)17:1636-1648)发表了一种计算算法,用于辨别 HIV-1 蛋白酶的特异性决定残基。在本文中,我们提出了两种源自 Chaudhury 和 Gray 算法的计算工具,旨在重新设计 HIV-1 蛋白酶。首先,我们提出了一种仅基于能量的方法来区分 HIV-1 蛋白酶野生型和突变型的可切割和不可切割肽。其次,我们展示了一种我们开发的算法,用于预测能够切割新靶标肽的突变 HIV-1 蛋白酶,该肽不同于 HIV-1 蛋白酶的天然靶标。使用仅基于能量的方法,我们根据可切割性和对靶肽的特异性对获得的计算机突变酶进行了分析。我们发现两种突变蛋白酶是针对靶序列的特异性和可切割性的最佳候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/5caa782e20a5/pone.0095833.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/33667e36efcb/pone.0095833.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/12c2607b9f7d/pone.0095833.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/9ee2cb3d97a8/pone.0095833.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/c41c1ee7bd94/pone.0095833.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/c0ecebef1e68/pone.0095833.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/5caa782e20a5/pone.0095833.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/33667e36efcb/pone.0095833.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/12c2607b9f7d/pone.0095833.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/9ee2cb3d97a8/pone.0095833.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/c41c1ee7bd94/pone.0095833.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/c0ecebef1e68/pone.0095833.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1776/4010418/5caa782e20a5/pone.0095833.g006.jpg

相似文献

1
In silico prediction of mutant HIV-1 proteases cleaving a target sequence.计算预测突变 HIV-1 蛋白酶切割靶序列。
PLoS One. 2014 May 5;9(5):e95833. doi: 10.1371/journal.pone.0095833. eCollection 2014.
2
Computational analysis of HIV-1 protease protein binding pockets.HIV-1 蛋白酶蛋白结合口袋的计算分析。
J Chem Inf Model. 2010 Oct 25;50(10):1759-71. doi: 10.1021/ci100200u.
3
Comparative studies on inhibitors of HIV protease: a target for drug design.HIV蛋白酶抑制剂的比较研究:药物设计的一个靶点
In Silico Biol. 2008;8(5-6):427-47.
4
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.与HIV-1蛋白酶失活突变体紧密结合的肽的计算设计与实验研究。
Proteins. 2008 Feb 15;70(3):678-94. doi: 10.1002/prot.21514.
5
Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease.HIV-1蛋白酶逃避抗性拟肽抑制剂的共进化分析
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1369-74. doi: 10.1073/pnas.96.4.1369.
6
Advances in automated docking applied to human immunodeficiency virus type 1 protease.应用于1型人类免疫缺陷病毒蛋白酶的自动对接技术进展。
Methods Enzymol. 1994;241:354-70. doi: 10.1016/0076-6879(94)41073-9.
7
Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.人免疫缺陷病毒1型蛋白酶紧密结合抑制剂的设计
Methods Enzymol. 1994;241:311-34. doi: 10.1016/0076-6879(94)41071-2.
8
Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach.
J Protein Chem. 1993 Jun;12(3):291-302. doi: 10.1007/BF01028191.
9
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.一组非活性位点突变在HIV-1蛋白酶耐药性发展中起主要作用。
Biochemistry. 2003 Jan 28;42(3):631-8. doi: 10.1021/bi027019u.
10
Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease.基于对称性的人免疫缺陷病毒蛋白酶拟肽抑制剂的设计。
Methods Enzymol. 1994;241:334-54. doi: 10.1016/0076-6879(94)41072-0.

引用本文的文献

1
Hypothesis on (Bartram) small extract inhibition of prostatic 5-reductase through an approach on 5-reductase x-ray structure.关于(巴特拉姆)小提取物通过对5-还原酶X射线结构的研究方法抑制前列腺5-还原酶的假说。
PeerJ. 2016 Nov 22;4:e2698. doi: 10.7717/peerj.2698. eCollection 2016.

本文引用的文献

1
Nonpolar Solvation Free Energies of Protein-Ligand Complexes.蛋白质-配体复合物的非极性溶剂化自由能
J Chem Theory Comput. 2010 Nov 9;6(11):3558-68. doi: 10.1021/ct100272s. Epub 2010 Sep 28.
2
HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern.HIV-1蛋白酶与底物的共同进化验证了底物包膜作为底物识别模式。
J Chem Theory Comput. 2012 Feb 14;8(2). doi: 10.1021/ct200668a.
3
Update of the drug resistance mutations in HIV-1: March 2013.2013年3月HIV-1耐药性突变的更新情况
Top Antivir Med. 2013 Feb-Mar;21(1):6-14.
4
Commercial proteases: present and future.商业蛋白酶:现状与未来。
FEBS Lett. 2013 Apr 17;587(8):1155-63. doi: 10.1016/j.febslet.2012.12.019. Epub 2013 Jan 11.
5
FragIt: a tool to prepare input files for fragment based quantum chemical calculations.FragIt:用于准备基于片段的量子化学计算输入文件的工具。
PLoS One. 2012;7(9):e44480. doi: 10.1371/journal.pone.0044480. Epub 2012 Sep 18.
6
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.HIV-1 蛋白酶的结构、动力学和热力学特异性设计研究。
Protein Sci. 2012 Jul;21(7):1029-41. doi: 10.1002/pro.2086. Epub 2012 Jun 5.
7
Prediction of HIV-1 protease/inhibitor affinity using RosettaLigand.使用 RosettaLigand 预测 HIV-1 蛋白酶/抑制剂亲和力。
Chem Biol Drug Des. 2012 Jun;79(6):888-96. doi: 10.1111/j.1747-0285.2012.01356.x. Epub 2012 Mar 19.
8
Open Babel: An open chemical toolbox.Open Babel:一个开放的化学工具箱。
J Cheminform. 2011 Oct 7;3:33. doi: 10.1186/1758-2946-3-33.
9
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.HIV-1 蛋白酶中优先底物识别的动力学:重新定义底物信封。
J Mol Biol. 2011 Jul 22;410(4):726-44. doi: 10.1016/j.jmb.2011.03.053.
10
Practically useful: what the Rosetta protein modeling suite can do for you.切实有用:罗氏蛋白建模套件能为您做什么。
Biochemistry. 2010 Apr 13;49(14):2987-98. doi: 10.1021/bi902153g.